STPH
- Amundi US Curve steepening 2-10Y UCITS ETF GBP Hedged DistKey Information
| Earliest date | 2020-10-19 |
| Exchange | CSE |
| Instrument Type | Common Stock |
| Sector | Healthcare |
| MIC Code | XCNQ |
| Website | https://www.steephill.com |
| CEO | Mr. Sameet Kanade CPA, MBA |
| Address | 30 Commercial Road |
| Country | Canada |
| State | ON |
| City | Toronto |
| Industry | Drug Manufacturers—Specialty & Generic |
ETF Information
| Fund Provider | Amundi |
| Index | Solactive USD Daily (x7) Steepener 2-10 (GBP Hedged) |
| Expense Ratio | 0.35% |
| Inception Date | 2023-05-16 |
| Asset Class | Bonds |
| Other Symbols | STPH |
| Currency | GBP |
| Distribution Policy | Distributing |
| Currency Hedged | |
| Listing | EU-listed |
| Bond Type | Government Bonds |
| Non-leveraged | Leveraged |
About STPH
The Amundi US Curve steepening 2-10Y UCITS ETF GBP Hedged Dist is an exchange-traded fund that tracks the Solactive USD Daily (x7) Steepener 2-10 (GBP Hedged) index, which aims to capture changes in the US yield curve. The fund uses a systematic strategy to achieve this, with a long position in 2-year US Treasury bond futures and a short position in 10-year US Treasury ultra bond futures. The ETF is currency hedged to British Pound (GBP) and has a total expense ratio of 0.35% p.a..